semaglutide .75 7.2mg achieved 20.7% weight loss in STEP UP obesity trial like peptide Ozempic (semaglutide): Uses, Side Effects,

Elaborating the results, semaglutide and the GLP-1/GLP-1R signaling system play a pivotal role in glucose regulation by enhancing insulin synthesis though the cAMP-dependent PKA/PI3K pathway, inhibition of pancreatic -cells apoptosis through AMPK and cAMP-activated CREB and proliferation of pancreatic -cells by regulation of downstream effector molecules like FOXO1

Maintenance Dosing: Once the desired therapeutic effect is achieved, a maintenance dose is established

This can help reduce the risk of heart attack or stroke in individuals who are at risk due to obesity

Development timeline : Survodutide Phase 3 results are expected sooner (H1 2026 for obesity), potentially reaching market before retatrutide

( E ) Representative tracings showing LVDP recordings from isolated, perfused WT hearts treated with GLP-1(2836) or GLP-1 or with buffer only or scrambled(2836) (Scram) controls

Our systematic analysis of GLP-1 agonists impact on IBS-related pain and symptoms suggests a promising landscape for its use beyond standard metabolic applications